Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia

Blood

Volumn 98, Issue 5, 2001, Pages 1577-1584

  De Jong, Kitty ^a   Emerson, Renee K ^a   Butler, James ^a   Bastacky, Jacob ^a   Mohandas, Narla ^a   Kuypers, Frans A ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; GAMMA GLOBIN; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; SICKLE CELL; SICKLE CELL ANEMIA; SPLEEN; STEM CELL;

EID: 0035469888     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.5.1577     Document Type: Article

References (27)

1. Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled Annexin V. Blood. 1996;87:1179-1187.
2. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
3. Styles LA, De Jong K, Vichinsky E, et al. Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening [abstract]. Blood. 1997;90:604.
4. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405:85-90.
5. Krahling S, Callahan MK, Williamson P, Schlegel RA. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 1999;6:183-189.
6. Shiratsuchi A, Osada S, Kanazawa S, Nakanishi Y. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem Biophys Res Commun. 1998;246:549-555.
7. Franco RS, Lohmann J, Silberstein EB, et al. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest. 1998;101:2730-2740.
8. De Jong K, Larkin SK, Styles LA, Bookchin RM, Kuypers FA. Characterization of the phosphatidylserine-exposing subpopulation of sickle cells. Blood. 2001;98:860-867.
9. Daniels G, Green C. Expression of red cell surface antigens during erythropoiesis. Vox Sang. 2000;78(suppl 2):149-153.
10. Paszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278:876-878.
11. Nagel RL. A knockout of a transgenic mouse: animal models of sickle cell anemia. N Engl J Med. 1998;339:194-195.
12. min-globlin genes in embryonic stem cells. Proc Nat Acad Sci U S A. 1995;92:9259-9263.
13. Kuypers FA, Scott MD, Schott MA, Lubin BH, Chiu DT-Y. Use of ektacytometry to determine red cell susceptibility to oxidative stress. J Lab Clin Med. 1990;116:535-545.
14. De Jong K, Geldwerth D, Kuypers FA. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry. 1997;36:6768-6776.
15. Martin SJ, Reutelingsperger CPM, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
16. Auffray I, Marfatia S, De Jong K, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood. 2001;97:2872-2878.
17. Popp RA, Popp DM, Johnson FM, Skow LC, Lewis SE. Hematology of a murine beta-thalassemia: a longitudinal study. Ann N Y Acad Sci. 1985;445:432-444.
18. Landaw SA. Homeostasis, survival, and red cell kinetics: measurement and imaging of red cell production. In: Hoffman R, Benz EJJ, Shattil SJ, Furie B, Cohen HJ, eds. Hematology, Basic Principles and Practice. New York, NY: Churchill Livingstone; 1991:274-290.
19. Blouin MJ, De Paepe ME, Trudel M. Altered hematopoiesis in murine sickle cell disease. Blood. 1999;94:1451-1459.
20. Gahmberg CG, Jokinen M, Andersson LC. Expression of the major sialoglycoprotein (glycophorin) on erythroid cells in human bone marrow. Blood. 1978;52:379-387.
21. Kuypers FA, Shiffer KA, Emerson RK, De Jong K, Ma L, Schrier SL. Analysis of erythropoiesis and red cell survival in murine beta-thalassemia [abstract]. Blood. 1998;92:533.
22. Pootrakul P, Sirankapracha P, Hemsorach S, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood. 2000;96:2606-2612.
23. Franco RS, Yasin Z, Lohmann JM, et al. The survival characteristics of dense sickle cells. Blood. 2000;96:3610-3617.
24. Kuypers FA. Phospholipid asymmetry in health and disease. Curr Opin Hematol. 1998;5:122-131.
25. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132.
26. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
27. Westerman MP, Green D, Gilman-Sachs A, et al. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med. 1999;134:352-362.